Submissions from 2024
Patient-specific quality assurance of dynamically-collimated proton therapy treatment plans, Alonso Gutierrez, Eduardo Pons, and Andrew Wroe
Low contralateral failure rate with unilateral proton beam radiotherapy for oropharyngeal squamous cell carcinoma: A multi-institutional prospective study from the proton collaborative group, Noah Kalman and Robert Press
Utility of TTMV-HPV DNA in resolving indeterminate findings during oropharyngeal cancer surveillance, Noah Kalman and Sreenija Yarlagadda
Association between high risk of obstructive sleep apnea and inflammatory markers in a population sample of young and middle-aged adults in the Miami Heart Study, Atulya Khosla, Khurram Nasir, Anshul Saxena, Theodore Feldman, Jonathan Fialkow, Harneet Walia, Javier Valero-Elizondo, and Shozab Ali
Establishing Updated Safety Standards for Independent (99)(m)Tc-MAA SPECT/CT Treatment Planning in Radioembolization, Taehyung Kim, Ripal Gandhi, Ranjini Tolakanahalli, Raul Herrera, Michael Chuong, Alonso Gutierrez, and Diane Alvarez
Long-term survival and safety of elranatamab in patients with relapsed or refractory multiple myeloma: Update from the MagnetisMM-3 study, Guenther Koehne
Recent advances in Tumor Treating Fields (TTFields) therapy for glioblastoma, Rupesh Kotecha
Early experience and perioperative risk of GammaTile for upfront brain metastases: Report from a prospective multicenter study, Rupesh Kotecha and Manmeet Ahluwalia
How proton therapy fits into the management of adult intracranial tumors, Rupesh Kotecha, Alonso La Rosa De Los Rios, and Minesh Mehta
In Regard to Trifiletti et al, Rupesh Kotecha and Minesh Mehta
Multidisciplinary Management of Isocitrate Dehydrogenase-Mutated Gliomas in a Contemporary Molecularly Defined Era, Rupesh Kotecha and Minesh Mehta
A Phase I/II Study to assess safety and preliminary evidence of a therapeutic effect of azeliragon combined with stereotactic radiation therapy in patients with brain metasteses, Rupesh Kotecha, Yazmin Odia, Zhijian Chen, Amy K. Starosciak, Alonso La Rosa de los Rios, Susana Herrera, Miguel Ramirez Menendez, Cristina Pow-Sang, Suyen Ramos, Jennifer Perez, Manmeet Ahluwalia, and Minesh Mehta
Stereotactic Body Radiotherapy for liver metastases: Systematic review and meta-analysis with International Stereotactic Radiosurgery Society (ISRS) Practice Guidelines, Rupesh Kotecha and Zhenwei Zhang
Implementation Strategies to Promote Short-Course Radiation for Bone Metastases, Rahul Kumar and Joseph Panoff
Incidence and outcomes of postoperative fluid collections after minimally invasive distal pancreatectomy without placement of surgical drain. A prospective observational cohort study, Filipe Kunzler, Domenech Asbun, Ramon Jimenez, and Horacio Asbun
Incidence and outcomes of postoperative fluid collections after minimally invasive distal pancreatectomy without placement of surgical drain. A prospective observational cohort study, Filipe Kunzler, Domenech Asbun, Ramon Jimenez, and Horacio Asbun
Surgically targeted radiation therapy versus stereotactic radiation therapy: A dosimetric comparison for brain metastasis resection cavities, Tugce Kutuk, Rupesh Kotecha, Raul Herrera, D Jay Wieczorek, Zachary Fellows, Vibha Chaswal, Alonso La Rosa De Los Rios, Vivek Mishra, Michael McDermott, Vitaly Siomin, Minesh Mehta, Alonso Gutierrez, and Ranjini Tolakanahalli
Surgically targeted radiation therapy versus stereotactic radiation therapy: A dosimetric comparison for brain metastasis resection cavities, Tugce Kutuk, Rupesh Kotecha, Raul Herrera, D Jay Wieczorek, Zachary Fellows, Vibha Chaswal, Alonso La Rosa De Los Rios, Vivek Mishra, Michael McDermott, Vitaly Siomin, Minesh Mehta, Alonso Gutierrez, and Ranjini Tolakanahalli
Interdisciplinary Collaboration in Head and Neck Cancer Care: Optimizing Oral Health Management for Patients Undergoing Radiation Therapy, Tugce Kutuk, Alessandro Villa, and Noah Kalman
Interdisciplinary Collaboration in Head and Neck Cancer Care: Optimizing Oral Health Management for Patients Undergoing Radiation Therapy, Tugce Kutuk, Alessandro Villa, Noah Kalman, and Adeel Kaiser
Comparative evaluation of outcomes amongst different radiosurgery management paradigms for patients with large brain metastasis, Tugce Kutuk, Yanjia Zhang, Eyub Akdemir, Sreenija Yarlagadda, Ranjini Tolakanahalli, Matthew Hall, Alonso La Rosa De Los Rios, D Jay Wieczorek, Cecilia Lee, Haley Appel, Michael McDermott, Yazmin Odia, Manmeet Ahluwalia, Alonso Gutierrez, Minesh Mehta, Rupesh Kotecha, and Robert Press
Accelerated Hypofractionated Magnetic Resonance Guided Adaptive Radiation Therapy for Ultracentral Lung Tumors, Alonso La Rosa de los Rios, Kathryn Mittauer, Nema Bassiri-Gharb, Amy Rzepczynski, Michael Chuong, Sreenija Yarlagadda, Tugce Kutuk, Nicole McAllister, Matthew Hall, Alonso Gutierrez, Ranjini Tolakanahalli, Minesh Mehta, and Rupesh Kotecha
Clinical application of an institutional fractionated stereotactic radiosurgery (FSRS) program for brain metastases delivered with MRIdian(Ⓡ) BrainTx™, Alonso La Rosa De Los Rios, Kathryn Mittauer, D Jay Wieczorek, Cecilia Lee, Amy Rzepczynski, Michael Chuong, Tugce Kutuk, Nicole McAllister, Matthew Hall, Alonso Gutierrez, Ranjini Tolakanahalli, Minesh Mehta, and Rupesh Kotecha
OUTREACH: Phase 2 study of lisocabtagene maraleucel as outpatient or inpatient treatment at community sites for R/R LBCL, Yuliya Linhares
Intraductal papillary neoplasms of the bile ducts: a comparative study of a rare disease in Europe and Nagoya, Japan, Nuria Lluis Vinas and Horacio Asbun
Immune Checkpoint Inhibitors in the Management of Brain Metastases from Non-Small Cell Lung Cancer: A Comprehensive Review of Current Trials, Guidelines and Future Directions, Arun Maharaj and Manmeet Ahluwalia
Immune Checkpoint Inhibitors in the Management of Brain Metastases from Non-Small Cell Lung Cancer: A Comprehensive Review of Current Trials, Guidelines and Future Directions, Arun Maharaj and Manmeet Ahluwalia
HER2+ early breast cancer treatment and outcomes by risk of recurrence: a retrospective US electronic health records study, Reshma Mahtani
Multi-Institutional Quality Improvement on HER2-Positive and HER2-Low Metastatic Breast Cancer, Reshma Mahtani
Expanding treatment options for patients with HER2+ metastatic breast cancer with margetuximab plus chemotherapy: a case report series, Reshma Mahtani and Natasha Harpalani
Sequencing Sacituzumab Govitecan (SG) AfteR Trastuzumab Deruxtecan (T-DXd) In ER+/HER2 LOW MetaStatic Breast Cancer, Reshma Mahtani, Ana Cristina Sandoval Leon, Maria Abreu, and Manmeet Ahluwalia
Multicenter retrospective cohort study of the sequential use of antibody drug conjugates (ADCs) trastuzumab deruxtecan (T-DXd) and sacituzumab govitecan (SG) in patients with HER2 low metastatic breast cancer (MBC): a subgroup analysis of next generation sequencing results., Reshma Mahtani, Mehmet Zerey, Ana Cristina Sandoval Leon, Lauren Carcas, Joseph Panoff, and Manmeet Ahluwalia
Racial and ethnic disparities in prostate cancer screening following the 2018 US Preventive Services Task Force recommendation statement, Murugesan Manoharan and Jorge Caso
A Machine Learning Approach To Predict Mortality Due To Immune-Mediated Thrombotic Thrombocytopenic Purpura, Camila Masias
A machine learning approach to predict mortality due to immune-mediated thrombotic thrombocytopenic purpura, Camila Masias Castanon
Evaluation of a non-metallic dual-port expander for intensity modulated proton therapy, Kristen McConnell, Zachary Fellows, James Kraus, Mauricio Acosta, Joseph Panoff, Eduardo Pons, Alonso Gutierrez, and Andrew Wroe
Evaluating the sensitivity of EQ-5D-5L in patients with brain metastases: a secondary analysis of NRG CC001, Minesh Mehta
Implications and interchangeability of meningioma biomarkers for clinical trials and clinical practice, Minesh Mehta
In Reply to Halperin, Minesh Mehta
NRG-BN002: Phase I Study of Ipilimumab, Nivolumab, and the Combination in Patients with Newly Diagnosed GBM, Minesh Mehta
NRG-BN002: Phase I study of ipilimumab, nivolumab, and the combination in patients with newly diagnosed glioblastoma, Minesh Mehta
The IDH paradox: Meta-analysis of alkylating chemotherapy in IDH-wild type and -mutant lower grade gliomas, Minesh Mehta
The IDH paradox: Meta-analysis of alkylating chemotherapy in IDH-wild type and -mutant lower grade gliomas, Minesh Mehta
The IDH paradox: Meta-analysis of alkylating chemotherapy in IDH-wildtype and -mutant lower grade gliomas, Minesh Mehta
The IDH paradox: Meta-analysis of alkylating chemotherapy in IDH-wildtype and -mutant lower grade gliomas, Minesh Mehta
Impact of removing ESBL status labelling from culture reports on the use of carbapenems for non-bacteraemic patients diagnosed with ESBL-positive urinary tract infections, Lourdes MenendezAlvarado, Alice Landayan, Kelsey Williams, Corey Frederick, Zhenwei Zhang, and Timothy Gauthier
Impact of removing ESBL status labelling from culture reports on the use of carbapenems for non-bacteraemic patients diagnosed with ESBL-positive urinary tract infections, Lourdes Menendez Alvarado, Alice Margulis Landayan, Kelsey Williams, Corey Frederick, Zhenwei Zhang, and Timothy Gauthier
Push/Pull Assignement Methodology, Danielle Miller
Commissioning Intracranial Stereotactic Radiosurgery for a Magnetic Resonance-Guided Radiation Therapy (MRgRT) System: MR-RT Localization and Dosimetric End-to-End Validation, Kathryn Mittauer, Ranjini Tolakanahalli, Rupesh Kotecha, Michael Chuong, Minesh Mehta, Alonso Gutierrez, and Nema Bassiri-Gharb
Irreversible Electroporation in Treating Colorectal Liver Metastases in Proximity to Critical Structures, Govindarajan Narayanan, Nicole Gentile, Jonathan Eyshi, Brian Schiro, Ripal Gandhi, Constantino Pena, Antonio Ucar, Santiago Aparo, Fernando de Zarraga, Sarah Joseph, Horacio Asbun, and Madelon Dijkstra
Diffuse midline glioma, H3K27-altered: Illuminating the dark side of the moon, Yazmin Odia
Safety and pharmacokinetics of ONC201 (dordaviprone) administered two consecutive days per week in pediatric patients with H3 K27M-mutant glioma, Yazmin Odia, Doured Daghistani, and Matthew Hall
Selective DRD2 antagonist and ClpP agonist ONC201 in a recurrent non-midline H3 K27M-mutant glioma cohort, Yazmin Odia and Matthew Hall
ONC201 (Dordaviprone) in Recurrent H3 K27M-Mutant Diffuse Midline Glioma, Yazmin Odia and Minesh Mehta
ONC201 (Dordaviprone) in Recurrent H3 K27M-Mutant Diffuse Midline Glioma, Yazmin Odia and Minesh Mehta
MGMT Methylation and Differential Survival Impact by Sex in Glioblastoma, Ahmad Ozair and Manmeet Ahluwalia
Implementation Strategies to Promote Short-Course Radiation for Bone Metastases, Joseph Panoff
Impact of an Interdisciplinary Team on Patients Seen at a Heart Failure Clinic, Nilda Pelegrino, Faaria Quadri, Elaina Rosario, Jacqualine Igwe, Sandra Chaparro, Lourdes Labrada, Sara Panella, Maria Pulido, Stephen Breazeale, and Zhenwei Zhang
Outpatient administration of CAR T-cell therapy: a focused review with recommendations for implementation in community based centers, Ariel Perez, Tiba Al Sagheer, George Nahas, and Yuliya Linhares
Assessment of Appropriate Anticoagulation in Multiple Myeloma Patients- a Health System Specialty Pharmacy Retrospective Evaluation, Addie Planas, Beatriz Jimenez-Cadilla, Brittany Alvarez, Cristina Vargas, Jacqualine Igwe, Karina Gonzalez-Jacobo, Maria Pulido, and Michelle Linh Le
Using Teach-Back Method to Improve Utilization of Epress Symptom Management Unit (ESMU), Gail Pollen and Dr. Arvinder Singh
A comparative study of survival outcomes between partial and radical cystectomy in octogenarians with muscle-invasive bladder cancer, Arjun Pon Avudaiappan, Pushan Prabhakar, Mohammad Arfat Ganiyani, Muni Rubens, Rohan Garje, Ahmed Eldefrawy, and Murugesan Manoharan
Pathological response and survival outcomes after neoadjuvant chemotherapy with radical cystectomy in octogenarians for muscle-invasive bladder cancer: an observational database study, Arjun Pon Avudaiappan, Pushan Prabhakar, Muni Rubens, Rohan Garje, Ahmed Eldefrawy, and Murugesan Manoharan
Proton Therapy for Spinal Tumors: A Consensus Statement From the Particle Therapy Cooperative Group, Robert Press
Proton Therapy for Spinal Tumors: A Consensus Statement From the Particle Therapy Cooperative Group, Robert Press
Proton Therapy: Current Status and Controversies, Robert Press and Minesh Mehta
A Bibliometric Analysis of the 500 Most Cited Papers in Orthopaedic Oncology, Juan Pretell
Bone Radiation-Induced Sarcomas: Outcomes Based on Histology and Surgical Treatment: A Systematic Review of the Literature, Juan Pretell
Failure Modes in Orthopedic Oncologic Reconstructive Surgery: A Review of Imaging Findings and Failure Rates, Juan Pretell
Pseudolesions involving bone and soft tissue regarding orthopedic oncology, Juan Pretell
Phase I Study of Fianlimab, a Human Lymphocyte Activation Gene-3 (LAG-3) Monoclonal Antibody, in Combination With Cemiplimab in Advanced Melanoma, Guilherme Rabinowits
Integrative Bioinformatics-Gene Network Approach Reveals Linkage between Estrogenic Endocrine Disruptors and Vascular Remodeling in Peripheral Arterial Disease, Venkataraghavan Ramamoorthy and Muni Rubens
Evaluation of a Partial Single Arc For Prostate SBRT Proton Treatment Planning According To RTOG 0938 Protocol, Suresh Rana